TargetLysophosphatidic acid receptor 5(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 800nMAssay Description:Antagonist activity at LPA5 receptor in human washed platelets assessed as inhibition of hexadecyl-LPA-induced platelet aggregation after 3 minsMore data for this Ligand-Target Pair
TargetLysophosphatidic acid receptor 5(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 800nMAssay Description:Antagonist activity at human recombinant LPA5 receptor expressed in rat RH7777 cells assessed as inhibition of hexadecyl-LPA-induced effectMore data for this Ligand-Target Pair
TargetLysophosphatidic acid receptor 5(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: 2.20E+3nMAssay Description:Antagonist activity at LPA5 receptor in human isolated platelets assessed as inhibition of hexadecyl-LPA-induced platelet aggregation after 3 minsMore data for this Ligand-Target Pair
TargetLysophosphatidic acid receptor 2(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Antagonist activity at LPA2 receptor in human isolated platelets assessed as inhibition of TRAP-induced platelet aggregation after 3 minsMore data for this Ligand-Target Pair
TargetLysophosphatidic acid receptor 5(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Antagonist activity at LPA5 receptor in human isolated platelets assessed as inhibition of hexadecyl-LPA-induced platelet aggregation after 3 minsMore data for this Ligand-Target Pair
TargetLysophosphatidic acid receptor 5(Homo sapiens (Human))
Sanofi-Aventis Deutschland
Curated by ChEMBL
Sanofi-Aventis Deutschland
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Antagonist activity at LPA5 receptor in human isolated platelets assessed as inhibition of hexadecyl-LPA-induced platelet aggregation after 3 minsMore data for this Ligand-Target Pair